A growing number of studies have documented that Keap1/Nrf2/HO-1 signaling mitigates oxidative stress damage by upregulating antioxidant defenses and reducing free radicals and is also an important regulator of many cytoprotective genes; it is considered a potential target for the treatment of various liver diseases. This evidence concerns the gene HMOX1 and liver disorder.